PLOD2 and renal cell carcinoma: PLOD2 was found to be overexpressed in bladder cancer [16], oral carcinoma [17], hepatocellular carcinoma [18], breast cancer [19], sarcoma [20], and renal cell carcinoma [21] and was closely related to a poor prognosis.